hf10
Biologicalexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2009 (NCT01017185)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- hf10
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03259425 | Phase 2 | Dec 21, 2017 | Bristol-Myers Squibb, Takara Bio Inc., University of Utah |
| NCT01017185 | Phase 1 | Aug 1, 2009 | Takara Bio Inc., University of Pittsburgh |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Takara Bio Inc. | For profit | 2 | 1 | 2 | 2009 |
| Bristol-Myers Squibb | For profit | 1 | 0 | 1 | 2017 |
| University of Pittsburgh | Academic/Hospital | 1 | 0 | 1 | 2009 |
| University of Utah | Academic/Hospital | 1 | 1 | 1 | 2017 |
4 organizations
Page 1 / 1